Pharmaceutical / Drug Definition :
Thought to block postsynaptic dopamine receptors in brain and increase dopamine turnover rate, inhibiting signs and symptoms of psychosis.
FDA Detentions
Haloperidol (Haloperidol Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Haloperidol (Haloperidol Suppliers)
- Processors Haloperidol
- Repackers Haloperidol
- Relabelers Haloperidol
- Exporters Haloperidol
- Importers Haloperidol
For more information about Haloperidol, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
